Lean adipocyte oxylipin signaling restrains breast cancer through ferroptosis
Science · 10.09.2026 · 393 (6816)
DOI: 10.1126/science.aea4287 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science, erschienen am 10.09.2026. Verfasst von Meghan C Curtin und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, University of Utah, Salt Lake City, UT, USA. Hauptthemen laut MEDLINE: Adipocytes, Breast Neoplasms, Ferroptosis, Linoleic Acids. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIH HHS, NIDDK NIH HHS.
Abstract (Originalsprache)
Obesity increases breast cancer risk and tumor aggressiveness, yet the mechanisms underlying this association remain unclear. In this work, we identify a tumor-suppressive lipid signaling pathway in which mammary adipocytes secrete the oxylipin 9S-hydroxyoctadecadienoic acid (9S-HODE). 9S-HODE induces ferroptosis in breast cancer cells by disrupting iron homeostasis. Adipocytes in obese mammary tissue produce less 9S-HODE, and tumors in obese mice exhibit reduced ferroptosis. Accordingly, ferroptosis inhibition accelerates tumor growth in lean mice, and restoring 9S-HODE suppresses tumor growth in obese mice. In humans, mammary 9S-HODE content is inversely correlated with body mass index, and 9S-HODE inhibits patient-derived breast cancer organoid growth. These findings identify the loss of adipocyte-derived 9S-HODE as a mechanism by which obesity promotes breast cancer and suggest that the restoration of ferroptosis-inducing lipid signaling may be a therapeutic strategy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry, University of Utah, Salt Lake City, UT, USA.
- Department of Oncological Sciences, University of Utah, Salt Lake City, UT, USA.
- Metabolomics and Lipidomics Core, University of Utah School of Medicine, Salt Lake City, UT, USA.
- Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.
ORCID-Profile: Meghan C Curtin, Abigail E Jackson, Mark D Lee, Elisabeth A Brown, J Alan Maschek, David H Lum, James E Cox, Alana L Welm, Keren I Hilgendorf
Förderung
- NCI NIH HHS
- NIH HHS
- NIDDK NIH HHS
- National Institutes of Health
- U.S. Department of Defense
- American Cancer Society
- National Cancer Institute
- National Institute of Diabetes and Digestive and Kidney Diseases
Zitieren
APA
Curtin, M. C., Jackson, A. E., Lee, M. D., Brown, E. A., Maschek, J. A., Lum, D. H., Cox, J. E., Welm, A. L., & Hilgendorf, K. I. (2026). Lean adipocyte oxylipin signaling restrains breast cancer through ferroptosis. Science, 393(6816). https://doi.org/10.1126/science.aea4287
Vancouver
Curtin MC, Jackson AE, Lee MD, Brown EA, Maschek JA, Lum DH, et al. Lean adipocyte oxylipin signaling restrains breast cancer through ferroptosis. Science. 2026;393(6816). doi:10.1126/science.aea4287
BibTeX
@article{Curtin2026,
author = {Curtin, Meghan C and Jackson, Abigail E and Lee, Mark D and Brown, Elisabeth A and Maschek, J Alan and Lum, David H and Cox, James E and Welm, Alana L and Hilgendorf, Keren I},
title = {Lean adipocyte oxylipin signaling restrains breast cancer through ferroptosis},
journal = {Science},
year = {2026},
volume = {393},
number = {6816},
doi = {10.1126/science.aea4287}
}
EUVIMED